Supplemental material, sj-xlsx-5-dhj-10.1177_20552076231169846 for An integrated targeted metabolomics and network pharmacology approach to exploring the mechanism of ellagic acid against sleep depriv
BackgroundImmunotherapy combined with chemotherapy has improved outcomes in advanced gastric cancer (GC), but reliable biomarkers to predict clinical benefit remain limited. Metabolomics provides a co
Column headers as follows: TRANSCRIPT_ID, ID as from the Rockefeller A5 dataset; sampleA and sampleB, samples compared; logFC, log2 fold change (log base 2 of the fold change in gene expression betwee
Prostate cancer is characterized by heterogeneity in the clinical course that often does not to correlate with morphologic features of the tumor. Metastasis reflects the most adverse outcome of prosta